Not a good buy right now: price is sitting near resistance with weakening momentum (negative MACD) and no proprietary buy signals.
Trend is still broadly bullish (stacked moving averages), but near-term pattern stats point to a mild downside drift over the next day/week/month.
With earnings on 2026-02-25 (after hours), risk/reward today is not compelling for an impatient entry; better treated as a hold/avoid new buys until either a clean breakout above 172.3 or a pullback closer to support (170.2–169.7).
Technical Analysis
Price/Levels: Current 171.24, just above pivot 170.971; immediate resistance at R1 171.783 then R2 172.284; support at S1 170.159 then S2 169.658.
Trend: Bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) indicates an ongoing uptrend on a multi-timeframe basis.
Momentum: MACD histogram -0.996 (below 0) and negatively contracting suggests upside momentum is weakening and a short-term pause/pullback is plausible.
RSI: RSI_6 at 63.241 is neutral-to-slightly warm (not overbought), but not a strong “oversold buy” setup.
Pattern-based forward look: Similar-candlestick analysis implies ~60% odds of small declines (-1.27% next day, -0.43% next week, -0.62% next month), reinforcing “no rush to buy” at this level.
Near-term momentum is weakening (MACD below zero) while price is close to resistance (~171.8–172.3), increasing the odds of a stall/pullback.
Latest quarter profitability declined YoY (net income and EPS down), which can cap enthusiasm even with revenue growth.
News item provided appears unrelated to DHIL (merger-violation investigation references Black Hills Corp.), offering no clear positive catalyst for DHIL.
No notable hedge-fund or insider accumulation signals in the recent lookback (both neutral).
Net income: 13,550,611 (-7.47% YoY) — profitability down.
EPS: 4.99 (-6.73% YoY) — earnings power softened.
Overall: mixed quarter (growth in revenue but deterioration in earnings), which reduces urgency to buy at resistance ahead of earnings.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price-target change data was provided, so no confirmed recent trend in Street upgrades/downgrades.
Wall Street pros/cons view (inferred from provided fundamentals/technicals only): Pros—steady revenue growth and an intact longer-term uptrend; Cons—recent EPS/net income contraction and weakening near-term momentum.
Influence/flow checks: No recent congress trading data available; hedge funds and insiders show neutral activity (no strong conviction signal).
Wall Street analysts forecast DHIL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DHIL is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast DHIL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DHIL is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
